To ascertain the pathway responsible for LRIG3-mediated VEGFA expression, we used the specific inhibitors of the ERK (PD98059) and AKT (LY292004) pathways to block their activation in glioma cells following LRIG3 knockdown. This evidence concerns the gene AKT1 and central nervous system cancer.